申请人:Array Biopharma, Inc.
公开号:US08022223B2
公开(公告)日:2011-09-20
Provided are compounds of formula I that are useful in the treatment and/or prevention of diseases mediated by deficient levels of glucokinase activity, such as diabetes meilitus. Also provided are methods of treating or preventing diseases and disorders characterized by underactivity of glucokinase or which can be treated by activating glucokinase.
提供了I式化合物,可用于治疗和/或预防由葡萄糖激酶活性不足引起的疾病,例如糖尿病。还提供了治疗或预防葡萄糖激酶活性不足或可以通过激活葡萄糖激酶治疗的疾病和紊乱的方法。